硫酸类肝素-3-O-磺基转移酶B1对乙型肝炎病毒复制的影响
류산류간소-3-O-광기전이매B1대을형간염병독복제적영향
Down-regulation of hepatitis B virus replication by heparin sulfate-D-glucosaminyl-3-O-sulfotransferase 3B1
  • 万方数据
    中华肝脏病杂志 중화간장병잡지
    CHINESE JOURNAL OF HEPATOLOGY
    2011年 6期 417-422 ,共6页

    苏怀彬%罗强%张祯祯%胡接力%黄爱龙

    소부빈%라강%장정정%호접력%황애룡

    肝炎病毒,乙型%硫酸类肝素-3-O-磺基转移酶B1%复制中间体 肝炎病毒,乙型%硫痠類肝素-3-O-磺基轉移酶B1%複製中間體
    간염병독,을형%류산류간소-3-O-광기전이매B1%복제중간체
    Hepatitis B virus%Heparin sulfate-D-glucosaminyl-3-o-sulfotransferase 3B1%Replication intermediate
    目的 研究硫酸类肝素-3-O-磺基转移酶B1(HS3ST381)对HBV复制的影响.方法 以HepG2细胞为阴性对照组,转染2.5μg pCH9-HBV(HBV表达质粒)的HepG2细胞为阳性对照组;转染了2.5μg pCH9-HBV、1.5 μg pcDNA3.1(HS3ST3B1表达质粒载体)和2.0μgpTZU6+1(干扰质粒构建载体)的HepG2细胞为对照组;转染了2.5μg pCH9-HBV、1.5 μgpCDNA3.1-HS3ST381和2.0 μg pTZU6+1的HepG2细胞为实验组A;转染了2.5 μg pCH9-HBV、1.5 μg pCDNA3.1-HS3ST381和2.0μg psh1126(HS3ST381的干扰质粒)的HepG2细胞为干扰组A.转染了2.5μg pCH9-HBV和2.0 μg pTZU6+1的HepG2细胞为实验组B;转染了2.5μgpCH9-HBV和2.0μg psh1126的HepG2为干扰组B.采用Southern blot和实时聚合酶链式反应技术检测HS3ST381共转染处理及未共转染处理的细胞内HBV复制中间体含量和病毒总RNA表达量,用双荧光素酶报告系统检测这种变化与HBV启动子[核心启动子(cp)、X蛋白启动子(xp)、包膜蛋白启动子1(sp1)、包膜蛋白启动子2(sp2)]活性的关系.采用SPSS17.0统计软件进行单因素方差分析,P<0.05为差异有统计学意义.结果以对照组HBV DNA含量为1,实验组A、干扰组A HBV DNA含量分别为10%±2%、31%±4%,对照组与实验组A比较,F=20.8,P=0.034,差异有统计学意义.实验组A与干扰组A比较,F=24.9,P=0.021,差异有统计学意义.与干扰组B比较,试验组B HBV DNA水平上升了130%±11%.在HBV稳定表达细胞株中转染pCDNA3.1-HS3ST381分别为0.5、1.0、1.5μg时,HBV DNA水平分别是对照组的90.0%±3.1%、82.0%±2.3%、21.0%±1.9%,与对照组比较,F值分别为22.7、20.3、26.5,P值分别为0.029、0.041、0.015,差异均有统计学意义.实验组A HBV总RNA量为对照组总RNA量的17.0%±2.7%,两组比较,F=25.6,P=0.018,差异有统计学意义.干扰组A HBV总RNA的量恢复到对照组的74.0%±3.9%,实验组A与干扰组A比较,F=21.3,P=0.032,差异有统计学意义.但HS3ST381对总RNA的下调与HBV的启动子活性无关.结论HS3ST381对HBV复制和HBV总RNA水平均有下调作用,但总RNA的下调不是HS3ST381直接作用于HBV启动子的结果.
    목적 연구류산류간소-3-O-광기전이매B1(HS3ST381)대HBV복제적영향.방법 이HepG2세포위음성대조조,전염2.5μg pCH9-HBV(HBV표체질립)적HepG2세포위양성대조조;전염료2.5μg pCH9-HBV、1.5 μg pcDNA3.1(HS3ST3B1표체질립재체)화2.0μgpTZU6+1(간우질립구건재체)적HepG2세포위대조조;전염료2.5μg pCH9-HBV、1.5 μgpCDNA3.1-HS3ST381화2.0 μg pTZU6+1적HepG2세포위실험조A;전염료2.5 μg pCH9-HBV、1.5 μg pCDNA3.1-HS3ST381화2.0μg psh1126(HS3ST381적간우질립)적HepG2세포위간우조A.전염료2.5μg pCH9-HBV화2.0 μg pTZU6+1적HepG2세포위실험조B;전염료2.5μgpCH9-HBV화2.0μg psh1126적HepG2위간우조B.채용Southern blot화실시취합매련식반응기술검측HS3ST381공전염처리급미공전염처리적세포내HBV복제중간체함량화병독총RNA표체량,용쌍형광소매보고계통검측저충변화여HBV계동자[핵심계동자(cp)、X단백계동자(xp)、포막단백계동자1(sp1)、포막단백계동자2(sp2)]활성적관계.채용SPSS17.0통계연건진행단인소방차분석,P<0.05위차이유통계학의의.결과이대조조HBV DNA함량위1,실험조A、간우조A HBV DNA함량분별위10%±2%、31%±4%,대조조여실험조A비교,F=20.8,P=0.034,차이유통계학의의.실험조A여간우조A비교,F=24.9,P=0.021,차이유통계학의의.여간우조B비교,시험조B HBV DNA수평상승료130%±11%.재HBV은정표체세포주중전염pCDNA3.1-HS3ST381분별위0.5、1.0、1.5μg시,HBV DNA수평분별시대조조적90.0%±3.1%、82.0%±2.3%、21.0%±1.9%,여대조조비교,F치분별위22.7、20.3、26.5,P치분별위0.029、0.041、0.015,차이균유통계학의의.실험조A HBV총RNA량위대조조총RNA량적17.0%±2.7%,량조비교,F=25.6,P=0.018,차이유통계학의의.간우조A HBV총RNA적량회복도대조조적74.0%±3.9%,실험조A여간우조A비교,F=21.3,P=0.032,차이유통계학의의.단HS3ST381대총RNA적하조여HBV적계동자활성무관.결론HS3ST381대HBV복제화HBV총RNA수평균유하조작용,단총RNA적하조불시HS3ST381직접작용우HBV계동자적결과.
    Objective To investigate the effect of HS3ST3B1 on hepatitis B virus(HBV)replicaction.Methods HepG2 cells were classified into 7 groups according to the plasmids transfected: (1) Blank group,no plasmid transfected;2. Positive control,transfected with pCH9-HBV which permits HBV replication;(3)Negative control,transfected with pCH9-HBV + pcDNA3.1 + pTZU6+ 1;(4) Treatment A,transfected withpCH9-HBV + pCDNA3.1-HS3ST3B1 + pTZU6+1;(5) Interference A,transfected with pCH9-HBV +pCDNA3.1-HS3ST3B1 + psh1126 (a plasmid to interfere HS3ST3B1 expression);(6) Treatment B,transfected with pCH9-HBV + pTZU6+1;(7) Interference B,transfected with pCH9-HBV + psh1126. The levels of HBV DNA were detected in the above groups by Southern blotting. HBV total RNA of Negative control,Treatment A and Interference A were quantified by Real-time PCR to determine the influence of HS3ST3B1 over-expression on the HBV RNA transcription. The acitivitiy of the four HBV promoters[core promoter (cp),x promoter(xp),surface antigen promoter1(sp1),surface antigen promoter2 (sp2)]were assayed by Dual-Luciferase Reporter Assay System. The data was analyzed using one way ANOVA,with P < 0.05 indicaring statistically meaningful difference. Result Southern blot data revealed the level of HBV DNA in Treatment A and Interference A accounted for 10% ± 2% and 31% ± 4% of that in control. Compared with control,a statistical difference existed between Treatment A and Control,with F value equalling to 20.8 and P value equalling to 0.034 respectively. A statistical difference also existed between Interfere A and Treatment A,with F value equalling to 24.9 and P value eqalling to 0.021 respectively. The level of HBV DNA in Experiment B was raised by 130% ± 11% as compared to that in Interference B,and the levels of HBV DNA showed a dose-dependent decrease when H7 cells were transfected with 0.5,1.0,1.5μg pCDNA3.1-HS3ST3B1 respectively. Statistical differences existed between control and H7 transfected with different dose of pCDNA3.1-HS3ST3B1,with F values equalling to 22.7,20.3,26.5 and P values equalling to 0.029,0.041 and 0.015 respectively. Real-time PCR revealed that the HBV total RNA in Treatment A accounted for 17.0% ± 2.7%of that in control and there was a statistical difference between Treatment A and control,with F value equalling to 25.6 and P value equalling to 0.018. In addtion,HBV DNA in Interference A was restored to 74.0% ±3.9% of that in control,and there was also a statistical difference between Treatment A and Interference A,with F value equalling to 21.3 and P value equalling to 0.032. However,the downregulaiton of HBV total RNA had nothing to do with HBV promoters activity. Conclusion HS3ST3B1 can inhibit HBV replication and reduce the level of HBV total RNA,but the downregulation of HBV total RNA may not be the result of direct intereaction of HS3ST3B1 and HBV promoters.
    원문보기 원문다운로드 사이트로이동
저자의 최근 논문